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he goal of this panel was to identify key is-
sues in communicating and reporting health-
care economic evaluation information. Its specific
objectives were to:
• identify and prioritize key issues;
• describe the mechanisms for putting pharmaco-
economic and outcomes information and data
into the same operational format that decision-
makers use to make formulary decisions;
• identify the entities that are conducting/sup-
porting the research, the purpose of the re-
search, and their target audiences for commu-
nicating research results;
• discuss outlets of communication of research
results and ways to improve the effectiveness
of the outlets;
• discuss optimal formats for communication of
economic evaluation results;
• recommend next steps.
 
Background and Context
 
Given the time, effort, and resources invested in
the performance of health economic evaluations,
communicating the process and results of those
evaluations well is critical. Without clear and ef-
fective communication, these evaluations will not
live up to their potential to be useful and timely
tools for healthcare decision-makers.
The audiences at which health economic infor-
mation is directed are as diverse as the decisions
that must be made. From government policy-mak-
ers involved in the allocation of federal resources
to healthcare and biomedical research, through to
the patient who needs to play a knowledgeable
role in his or her own healthcare, each consum-
er of health economic information has specific
needs. Audiences of health economic information
include:
• government policy-makers;
• regulatory agencies;
• healthcare providers;
• healthcare professionals;
• the healthcare industry;
• researchers and educators;
• the public (e.g., consumers, patient interest
groups).
If the messages contained in a health economic
evaluation are to reach the intended audience, bar-
riers to the use of these evaluations must be recog-
nized and addressed. In order for this to happen,
the evaluations and their results must be:
• clear and understandable;
• acceptable to the audience with respect to both
content and design [1];
• communicated in the right way and at the right
time.
 
Problem Statement
 
Users of health economic information represent
many different perspectives with various levels of
expertise and information needs. To obtain the
most value from the resources invested in health
economic research, how do we optimize the effec-
tiveness of our communicating of health economic
information?
 
*The views expressed herein are those of the author and do
not necessarily represent the position of the Agency for
Health Care Policy and Research or the US Department of
Health and Human Services.
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Issues
 
These main areas for development have been iden-
tified as keys to more effective communication:
• Relevance: Is it needed?
• Usefulness: Will the intended audience be able
to make use of it?
• Credibility: Is it believable?
 
Relevance
 
Is the message relevant for its intended audience?
How well we meet the needs of the intended audi-
ence depends on how well we know them. Who
are they? What information do they need to make
appropriate choices? What is their decision-mak-
ing process? What is their level of understanding
and expertise?
This information can be obtained from numer-
ous sources. However, the target audience itself
should be involved in the delineation of its needs
and process, although assistance from the produc-
ers of health economic information may be needed,
according to the degree of experience of the user.
Among the points to be considered when evalu-
ating relevance are:
• the varied information needs of end-users and
their magnitude of importance;
• the changing environment or time constraints
in which decisions are being made;
• the predominant influence(s) over those mak-
ing them, for example, political, social, bud-
getary, clinical, or logistical.
There is often disagreement between researchers
and their audiences concerning relevance of research
design to the application of its results. Greater
awareness of both the intended purpose of the re-
search and the objectives of the user before the
study is designed may help to reduce that conflict.
 
Usefulness
 
Will the information be useful to its intended end-
user? These areas were identified as issues with re-
gard to the usefulness of health economic informa-
tion:
• reporting standards;
• communication formats;
• content.
 
Reporting Standards.
 
How much standardiza-
tion is wanted? There are distinct benefits to hav-
ing standard formats for health economic report-
ing structures. They allow for greater clarity and
understanding of the content, they create a sense
of familiarity with terminology and format that al-
lows faster integration of new information, and
they promote comparability across studies. For
educational purposes, they simplify the learning
process and facilitate the work of editors and re-
viewers in the review and evaluation of health eco-
nomic documents. Creating standard formats for
all types of health economic communications will
help end-users wade through the overload of in-
formation available, more quickly comprehend
the message, and be able to compare it for deci-
sion-making purposes.
Creation of reporting standards for all types of
health economic studies, clinical studies, model-
ing, and database studies, would necessarily be the
first step toward standards for publication in peer-
reviewed journals and elsewhere, and other modes
of communication such as public presentations
and posters, and formulary submissions.
 
Communication Formats.
 
What is the most ap-
propriate communication vehicle? Besides the
ones that are most familiar (abstracts, posters,
public presentations, reports and articles, health
economic communications), more and more com-
munications are taking place through other forms
of written communication such as targeted brief-
ing documents and various types of submissions
to healthcare providers, on an interpersonal level,
or through the mass media. Consideration should
be given to the usefulness of each type of commu-
nication, and its potential role in information
transfer.
 
Content.
 
How useful will the intended audiences
find the information content? Again, the users of
health economic information possess a variety of
backgrounds and expertise in this multidisci-
plinary field. The content of any message has to be
tempered according to the level of sophistication
of the users, as well as knowledge of the needs of
the audience. Managed care organizations have
different needs than do physicians, who may in
turn be looking for something different than con-
sumers. The key is knowing the needs and abilities
of an audience.
 
Credibility
 
No matter how well presented or potentially use-
ful health economic information may be, it will
not be used unless the audience finds it credible.
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To enhance the believability factor of health eco-
nomic information, three areas must be addressed:
1. accepted standards of practice;
2. the concept of disclosure;
3. validation of the information.
 
Accepted Standards of Practice.
 
Establishing stan-
dards of health economic performance is the man-
date of other panels, with respect to methodolo-
gies, ethics, bias, and conflict of interest. It is
important to note, though, that without a set of
standardized criteria on which to base judgment
of health economic information, only the most ex-
perienced audience will be able to feel (rationally)
confident about its acceptability.
 
The Concept of Disclosure.
 
The concept of dis-
closure includes more than simple transparency.
While transparency provides that all assumptions
and all influences that went into the creation of
the health economic information are revealed, dis-
closure goes beyond. The information provider
must furnish sufficient detail to enable the audi-
ence to make a relevant decision about the infor-
mation. The amount and sophistication of the de-
tail disclosed will vary according to the expertise
and the skills of intended user. At present this con-
cept is poorly developed; standardization of levels
of disclosure is needed.
 
Validation of Health Economic Information.
 
How much protection does the consumer of
health economic information want? That will
probably depend on the importance of the deci-
sion to be made and the discriminatory abilities of
the user to determine the quality of an analysis,
which will in turn depend on their training and
experience. There is no one appropriate level of
health economic background needed by all, but
clearly there is a need for a basic level of knowl-
edge for all users of health economic information
users (see panel 4, education and skills).
A systematized independent review process of
health economic research that provided a measure
of validity according to generally accepted stan-
dards would increase the level of credibility asso-
ciated with that research. It would confirm that a
study met acceptable design, methods, conduct,
format, disclosure, and presentation standards.
As a form of accreditation, this review would al-
low users to be more comfortable with reported
results.
 
Recommendations and Next Steps
 
To strengthen the relevance, usefulness, and credibil-
ity of health economic communication, six areas that
require future development have been identified.
 
Identification of Users and Their Needs
 
To extend the relevance of ongoing health eco-
nomic research, key users of health economic in-
formation should be identified, along with their
information needs. This should be a three-step
process involving all interested stakeholders, but
should be coordinated by an independent profes-
sional association such as ISPOR.
• Step 1: Perform a comprehensive evaluation of
the literature to determine what has already
been published on the subject.
• Step 2: Establish working groups that include
other interested professional organizations to
identify the relevant stakeholders, the types of
information needed, and the potential barriers
to communication that exist. This may be an
iterative process, including other stakeholders
at later stages.
• Step 3: With the information gathered in step
2, prepare and conduct a survey of all users of
health economic information, to provide a ba-
sis for standardization of communications.
 
Standard Communication Formats
 
To increase usefulness of health economic commu-
nications, establish standard communication for-
mats based on predetermined relevance, informa-
tion, and credibility needs of users and on standard
health economic performance standards that should
be under development elsewhere. These should
eventually include: (1) uniform presentation, (2)
standard terminology, (3) adequate disclosure, and
(4) a basis in previously published guidelines [2,3].
 
Reporting Guidances (RGs)
 
As standardized formats are established, reporting
guidance (RGs) should be adopted by ISPOR and
applied to all publicly presented communications,
including ISPOR’s journal. Other vehicles of com-
munication, such as other biomedical journals and
Internet publishers, should also be encouraged to
use these standards. ISPOR reporting guidance
should establish reporting standards for each ma-
jor study type, and over the long term, they should
be tailored to each specific type of audience as
well.
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Biannual Surveys
 
Performance surveys to evaluate the use of report-
ing guidance and the quality of reporting should
be undertaken on a biannual basis.
 
Public Accessibility
 
A principle of publicly accessible reports that ad-
here to ISPOR RGs should be established. This
would allow access to research reports that is not
directly controlled by the researcher or the re-
search organization. Once a report has been
“filed” for public accessibility, all subsequent
communications could refer to that report. Figure
1 illustrates a scheme for the development of a sys-
tem for public accessibility.
 
Enhanced Peer Review
 
An enhanced mode of peer review should be insti-
tuted for all forms of health economic communi-
cations. This type of review would assure that
there was compliance with ISPOR RGs and fair,
full, and adequate disclosure, allow for review of
the underlying data and any model used, and con-
firm that all other ISPOR standards for the con-
duct of health economic studies have been met.
 
Summary
 
Pharmacoeconomics has numerous diverse audi-
ences with various perspectives, objectives, back-
grounds, and skills. To get the most value from
health economic research we need to increase the
relevance, usefulness, and credibility of our com-
munications to these audiences. Only by ensuring
that we are aware of our audience’s true needs
and endeavoring to provide a product they can
understand and use, can we have the most impact
on decision-making with health economic tools.
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